Literature DB >> 21197122

Eighteen Month Outcomes for Clients Receiving Combined Outpatient Treatment and Sober Living Houses.

Douglas L Polcin1, Rachael Korcha, Jason Bond, Gantt Galloway.   

Abstract

One of the most frequent and frustrating challenges facing clients in outpatient treatment is finding a living environment that is free of alcohol and drugs and supportive of recovery. Sober Living Houses (SLHs) have been suggested as one potential solution (Polcin, 2009). Among other advantages, SLHs are financially self-sustaining and residents can remain there as long as they wish, provided they comply with house rules and expectations. This study examined 18-month outcomes for 55 individuals receiving outpatient treatment combined with residence in a SLH. Repeated measures analyses comparing 6-month time periods showed significant improvement on measures of alcohol and drug use, arrests, and days worked. The Addiction Severity Index (ASI) showed significant improvement on legal and employment scales. On ASI alcohol and drug scales, individuals entered SLHs with very low severity that was maintained at 18 months. Involvement in 12-step groups was associated with reductions in alcohol and drug use.

Entities:  

Year:  2010        PMID: 21197122      PMCID: PMC3008818          DOI: 10.3109/14659890903531279

Source DB:  PubMed          Journal:  J Subst Use        ISSN: 1465-9891


  11 in total

1.  Criminal justice coercion in the treatment of alcohol problems: an examination of two client subgroups.

Authors:  D L Polcin
Journal:  J Psychoactive Drugs       Date:  1999 Apr-Jun

2.  Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network.

Authors:  Robert F Forman; Dace Svikis; Ivan D Montoya; Jack Blaine
Journal:  J Subst Abuse Treat       Date:  2004-07

3.  A clean and sober place to live: philosophy, structure, and purported therapeutic factors in sober living houses.

Authors:  Douglas L Polcin; Diane McAllister Henderson
Journal:  J Psychoactive Drugs       Date:  2008-06

4.  The Alcoholics Anonymous Affiliation Scale: development, reliability, and norms for diverse treated and untreated populations.

Authors:  K Humphreys; L A Kaskutas; C Weisner
Journal:  Alcohol Clin Exp Res       Date:  1998-08       Impact factor: 3.455

5.  The effect of social environment on treatment outcomes in outpatient substance misuse treatment organizations: does race really matter?

Authors:  D L Howard; T A LaVeist; W C McCaughrin
Journal:  Subst Use Misuse       Date:  1996-04       Impact factor: 2.164

6.  Decomposing the relationships between pretreatment social network characteristics and alcohol treatment outcome.

Authors:  William H Zywiak; Richard Longabaugh; Philip W Wirtz
Journal:  J Stud Alcohol       Date:  2002-01

7.  To house or not to house: the effects of providing housing to homeless substance abusers in treatment.

Authors:  Jesse B Milby; Joseph E Schumacher; Dennis Wallace; Michelle J Freedman; Rudy E Vuchinich
Journal:  Am J Public Health       Date:  2005-07       Impact factor: 9.308

8.  The Fifth Edition of the Addiction Severity Index.

Authors:  A T McLellan; H Kushner; D Metzger; R Peters; I Smith; G Grissom; H Pettinati; M Argeriou
Journal:  J Subst Abuse Treat       Date:  1992

9.  A model for sober housing during outpatient treatment.

Authors:  Douglas L Polcin
Journal:  J Psychoactive Drugs       Date:  2009-06

10.  Effects of halfway house placement on retention of patients in substance abuse aftercare.

Authors:  H C Hitchcock; R D Stainback; G M Roque
Journal:  Am J Drug Alcohol Abuse       Date:  1995-08       Impact factor: 3.829

View more
  22 in total

1.  "I have more support around me to be able to change": A Qualitative Exploration of Probationers' and Parolees' Experiences Living in Sober Living Houses.

Authors:  Rebecca de Guzman; Rachael Korcha; Douglas L Polcin
Journal:  Ther Communities       Date:  2019-05-07

2.  Substance Abuse Treatment Patients in Housing Programs Respond to Contingency Management Interventions.

Authors:  Carla J Rash; Sheila M Alessi; Nancy M Petry
Journal:  J Subst Abuse Treat       Date:  2016-07-19

3.  Prevalence and Trajectories of Psychiatric Symptoms Among Sober Living House Residents.

Authors:  Doug Polcin; Rachael Korcha; Shalika Gupta; Meenakshi Sabina Subbaraman; Amy A Mericle
Journal:  J Dual Diagn       Date:  2016-04-15

4.  Interaction of motivation and psychiatric symptoms on substance abuse outcomes in sober living houses.

Authors:  Douglas L Polcin; Rachael A Korcha; Jason C Bond
Journal:  Subst Use Misuse       Date:  2014-10-07       Impact factor: 2.164

5.  Recovery Housing: Evolving Models to Address Resident Needs.

Authors:  Amy A Mericle; Douglas L Polcin; Jordana Hemberg; Jennifer Miles
Journal:  J Psychoactive Drugs       Date:  2017-06-28

6.  Several Common Bonds: Addressing the Needs of Gay and Bisexual Men in LGBT-Specific Recovery Housing.

Authors:  Amy A Mericle; Adam W Carrico; Jordana Hemberg; Rebecca de Guzman; Ronald Stall
Journal:  J Homosex       Date:  2019-01-07

7.  What did we learn from our study on sober living houses and where do we go from here?

Authors:  Douglas L Polcin; Rachael Korcha; Jason Bond; Gantt Galloway
Journal:  J Psychoactive Drugs       Date:  2010-12

8.  Distribution and Neighborhood Correlates of Sober Living House Locations in Los Angeles.

Authors:  Amy A Mericle; Katherine J Karriker-Jaffe; Shalika Gupta; David M Sheridan; Doug L Polcin
Journal:  Am J Community Psychol       Date:  2016-09-15

9.  Course of Psychiatric Symptoms and Abstinence among Methamphetamine-Dependent Persons in Sober Living Recovery Homes.

Authors:  Douglas L Polcin; Jane Witbrodt; Rachael Korcha; Shalika Gupta; Amy A Mericle
Journal:  J Psychoactive Drugs       Date:  2016-05-16

10.  Sober living house characteristics: A multilevel analyses of factors associated with improved outcomes.

Authors:  Amy A Mericle; Elizabeth Mahoney; Rachael Korcha; Kevin Delucchi; Douglas L Polcin
Journal:  J Subst Abuse Treat       Date:  2018-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.